Interventions for non-metastatic squamous cell carcinoma of the skin

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Lansbury, Louise ^a   Leonardi Bee, Jo ^a   Perkins, William ^b   Goodacre, Timothy ^c   Bath Hextall, Fiona J ^a   Tweed, John A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; INTERFERON;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CRYOSURGERY; HUMAN; LOW LEVEL LASER THERAPY; METASTASIS; PHOTODYNAMIC THERAPY; REVIEW; SKIN CARCINOMA;

EID: 70049092385     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007869     Document Type: Review

References (48)

1. Alam M, Ratner D. Primary care: cutaneous squamous-cell carcinoma. New England Journal of Medicine 2001;344(13):975-983. (Pubitemid 32695077)
2. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. Journal of Photochemistry and Photobiology B:Biology 2001;63(1-3):8-18.
3. Auerbach H. Geographic variation in incidence of skin cancer in the United States. Public Health Reports 1961;76(4):345-348
4. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, Macnaught A, O'Sullivan B, Siskin V, Van Der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia: A follow-up study. Transplantation 1996;61(5):715-721. (Pubitemid 26097231)
5. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville Australia. International Journal of Cancer 1998;78(5):587-593 (Pubitemid 28507182)
6. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatologic Surgery 2002;28:268-273 (Pubitemid 34259756)
7. De Hertog SAE, Wensveen CA, Bastiaens MT, Kielich CJ, Berkhout MJP, Westendorp RGJ. Relation between smoking and skin cancer. Journal of Clinical Oncology 2001;19(1):231-238
8. Demopoulos BP, Vamvakas E, Ehrlich JE, Demopoulos R. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Archives of Pathology and Laboratory Medicine 2003;127(5):589-592 (Pubitemid 36534944)
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-188.
10. Diepgen TL, Mahler V. The epidemiology of skin cancer. British Journal of Dermatology 2002;146(Suppl 61):1-6.
11. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. Journal of the American Academy of Dermatology 1989;21:241-248
12. Fine JD, Johnson LB, Suchidran C, Bauer EA, Carter DM, McGuire J. Cancer and inherited epidermolysis bullosa:lifetable analyses of the National Epidermolysis Bullosa Registry study population. In: Fine JD, Bauer EA, McGuire J, Moshell A editor(s). Epidermolysis bullosa: clinical, epidemiologic, and laboratory advances, and the findings of the national epidermolysis bullosa registry. Baltimore: John Hopkins University Press, 1999:175-192.
13. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, Threlfall WJ. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer:II. Squamous cell carcinoma. Archives of Dermatology 1995;131:164-169
14. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. Journal of the American Medical Association 1989;262(15):2097-2100
15. Gloster HM, Brodland DG. The epidemiology of skin cancer. Dermatologic Surgery 1996;22(3):217-226
16. Gloster HM, Neal K. Skin cancer in skin of color. Journal of the American Academy of Dermatology 2006;55(5):741-760.
17. Department of Health. The New NHS. Modern. Dependable. London. The Stationery Office Ltd 1997:Clause 1.13.
18. Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a sub-tropical Australian population: incidence and lack of association with occupation. American Journal of Epidemiology 1996;144(11):1034-1040 (Pubitemid 26404809)
19. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995;75(2):667-673
20. Hardie IR, Strong RW, Hartley LC, Woodruff PW, Clunie GJ. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980;87(2):177-183
21. Hartevelt MM, Bouwes Bavinck JN, Kootte AM, Vermeer BI, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49(3):506-509 (Pubitemid 20110465)
22. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Current Opinion in Infectious Diseases 2002;15(2):101-114. (Pubitemid 34272294)
23. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org 2008.
24. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales 1988-1998. British Journal of Dermatology 2000;143(6):1224-1229
25. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). Journal of the American Academy of Dermatology 1992;26(3):467-484
26. Kao GF. Carcinoma arising in Bowen's disease. Archives of Dermatology 1986;122(10):1124-1126
27. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JNB, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M. Human papillovirus infection and incidence of squamous cell and basal cell carcinomas of the skin. Journal of the National Cancer Institiute 2006;98(6):389-395.
28. Karagas MR, Nelson HH, Zens MS, Linet M, Stukel TA, Spencer S, Applebaum KM, Mott L, Mabuchi K. Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology 2007;18(6):776-784 (Pubitemid 350295177)
29. Katz KA, Marcil I, Stern RS. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet light-treated psoriasis patients. Journal of Investigative Dermatology 2002;118(6):1038-1043 (Pubitemid 34639184)
30. Leong GK, Stone JL, Farmer ER, Scotto J, Reizner GT, Burnett TS, Elpern DJ. Nonmelanoma skin cancer in Japanese residents of Kauai, Hawaii. Journal of the American Academy of Dermatology 1987;17:233-238
31. Lim JL, Stern RS. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. Journal of Investigative Dermatology 2005;124(3):505-513
32. Marks R, Foley P, Goodman G, Hage BH, Selwood TS. Spontaneous remission of solar keratoses: the case for conservative management. British Journal of Dermatology 1986;115(6):649-655 (Pubitemid 17181888)
33. Marks R. Squamous cell carcinoma. Lancet 1996;347(9003):735-738
34. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: Incidence. Journal of the American Academy of Dermatology 1994;30(5):774-780
35. Mora RG, Perniciaro C. Cancer of the skin in blacks.I. A review of 163 black people with cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology 1981;5(5):535-543 (Pubitemid 12221163)
36. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. British Journal of Dermatology 146;1:18-25.
37. Nijsten TEC, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: A cohort study. Journal of Investigative Dermatology 2003;121(2):252-258
38. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-2834 (Pubitemid 28562978)
39. Pennello G, Devesa S, Gail M. Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. Cancer Epidemiology Biomarkers and Prevention 2000;9:291-297 (Pubitemid 30165442)
40. Peterka ES, Lynch FW, Goltz RW. An association between Bowen's Disease and internal cancer. Archives of Dermatology 1961;84:623-629
41. Preston DS, Stern RS. Nonmelanoma cancers of the skin. New England Journal of Medicine 1992;327(23):1649-1662
42. Rowe DE, Carroll RJ, Day Jr CJ. Prognostic factors for local recurrence, metastasis and survival rates in squamous cell carcinoma of the skin, ear and lip: Implications for treatment modality selection. Journal of the American Academy of Dermatology 1992;26:976-990
43. Scotto J, Fears TR, Fraumeni JF Jr. Incidence of nonmelanoma skin cancer in the United States. Washington (DC): U.S. Government Printing Office, 1981. National Cancer Institute, DHSS Report No. NIH 82-2433 1981.
44. Sober AJ. Diagnosis and management of skin cancer. Cancer 1983;51(12 Suppl):2448-2452
45. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: The 2002 national survey and trends since 1985. Medical Journal of Australia 2006;184(1):6-10.
46. Stranc MF, Fogel M, Dische S. Comparison of lip function: surgery vs radiotherapy. British Journal of Plastic Surgery 1987;40(6):598-604.
47. Weinstock MA. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Archives of Dermatology 1993;129:1286-1290
48. Yu H-S, Liao W-T, Chai C-Y. Arsenic carcinogenesis in the skin. Journal of Biomedical Science 2006;13(5):657-666